Urinary C5b-9 excretion and clinical course in idiopathic human membranous nephropathy

Kidney International

Volumn 48, Issue 6, 1995, Pages 1953-1958

  Kon, Sui P ^a   Coupes, Beatrice ^b   Short, Colin D ^b   Solomon, Lawrence R ^b   Raftery, Martin J ^b   Mallick, Netar P ^b   Brenchley, Paul E ^b  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; COMPLEMENT COMPONENT C5B; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT OUTCOME; URINARY EXCRETION;

EID: 0028845893     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1995.496     Document Type: Article

References (34)

1. ROSEN S, TORNROTH T, BERNARD DB: Membranous glomerulonephritis, in Renal Pathology with Clinical and Functional Correlations, edited by TISCHER CC, BRENNER BM, Philadelphia, JB Lippincott Company, 1989, pp 196-227
2. HONKANEN E, TORNROTH T, GRONHAGEN-RISKA C: Natural history, clinical course and morphological evolution of membranous nephropathy. Nephrol Dial Transplant 7(Suppl 1):35-41, 1992
3. DONADIO JV, HOLLEY KE, ANDERSON CF, TAYLOR WF: Controlled trial of cyclophosphamide in idiopathic membranous nephropathy. Kidney Int 6:431-439, 1974
4. Collaborative study of the adult idiopathic nephrotic syndrome. Controlled study of short-term prednisone treatment in adults with membranous nephropathy. N Engl J Med 301:1301-1306, 1979
5. CATTRAN DC, DELMORE T, ROSCOE J, COLE E, CARDELLA C, CHARRON R, RITCHIE S: A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy. N Engl J Med 320:210-215, 1989
6. CAMERON JS, HEALY MJR, ADU D: The Medical Research Council Trial of short-term high-dose alternate day prednisolone in nephrotic syndrome in adults. Q J Med 74:133-156, 1990
7. PONTICELLI C, ZUCCHELLI P, PASSERINI P, CAGNOLI L, CESANA B, POZZI C, PASQUALI S, IMBASCIATI E, GRASSI C, REDAELLI B, SASDELLI M, LOCATELLI F: A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med 320:8-13, 1989
8. PONTICELLI C, ZUCCHELLI P, PASSERINI P, CESANA B: Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. N Engl J Med 327:599-603, 1992
9. SCHIEPPATI A, MOSCONI L, PERNA A, MECCA G, BERTANI T, GARATTINI S, REMUZZI G: Prognosis of untreated patients with idiopathic membranous nephropathy. N Engl J Med 329:85-89, 1993
10. SHORT CD, SOLOMON LR, GOKAL R, MALLICK NP: Methylprednisolone in patients with membranous nephropathy and declining renal function. Q J Med 65:929-940, 1987
11. MATHIESON PW, TURNER AN, MAIDMENT CGH, EVANS DJ, REES AJ: Prednisolone and chlorambucil treatment in idiopathic membranous nephropathy. Lancet 2:869-872, 1988
12. JINDAL K, WEST M, BEAR R, GOLDSTEIN M: Long-term benefits of therapy with cyclophosphamide and prednisone in patients with membranous glomerulonephritis and impaired renal function. Am J Kidney Dis 19:61-67, 1992
13. FALK RJ, HOGAN SL, MULLER KE, JENNETTE C: Treatment of progressive membranous glomerulopathy. A randomised trial comparing cyclophosphamide and corticosteroids and corticosteroids alone. Ann Intern Med 116:438-445, 1992
14. WAGONER RD, STANSON AW, HOLLEY K, WINTER CS: Renal vein thrombosis in idiopathic membranous glomerulopathy and the nephrotic syndrome. Incidence and significance. Kidney Int 23:368-374, 1983
15. JENNINGS M, SHORTLAND JR, MADDOCKS JL: Interstitial nephritis associated with frusemide. J Royal Soc Med 79:239-240, 1986
16. PETTERSSON E, TORNROTH T, MIETTINNEN A: Simultaneous antiglomerular basement membrane and membranous glomerulonephritis: Case report and literature review. Clin Immunol Immunopathol 31:171-180, 1984
17. SCHULZE M, DONADIO JV, PRUCHNO CJ, BAKER P, JOHNSON RJ, STAHL RAK, WATKINS S, MARTIN DC, WURZNER R, GOTZE O, COUSER WG: Elevated urinary excretion of the C5b-9 complex in membranous nephropathy. Kidney Int 40:533-538, 1991
18. BRENCHLEY PEC, COUPES BC, SHORT CD, O'DONOGHUE DJ, BALLARDIE FW, MALLICK NP: Urinary C3dg and C5b-9 indicate active immune disease in human membranous nephropathy. Kidney Int 41:933-937, 1992
19. PRUCHNO CJ, BURNS MW, SCHULZE M, JOHNSON RJ, BAKER PJ, ALPERS CE, COUSER WG: Urinary excretion of the C5b-9 membrane attack complex of complement is a marker of immune disease activity in autologous immune complex nephritis. Am J Pathol 138:203-211, 1991
20. SCHULZE M, BRUNCKHORST R, FREI U, KOCH KM: Elevated urinary C5b-9 excretion indicates progression of membranous nephropathy. (abstract) J Am Soc Nephrol 3:614, 1992
21. COUPES BM, KON SP, BRENCHLEY PEC, SHORT CD, MALLICK NP: Temporal relationship between urinary C5b-9 and C3dg and clinical parameters in human membranous nephropathy. Nephrol Dial Transplant 8:397-401, 1993
22. CHURG J, GRISHMAN E, GOLDSTEIN MH, YUNIS SL, PORUSH JG: Idiopathic nephrotic syndrome in adults: A study and classification based on renal biopsies. N Engl J Med 272:165-174, 1965
23. PONTICELLI C, ZUCCHELLI P, IMBASCIATI E, CAGNOLI L, POZZI C, PASSERINI P, GRASSI C, LIMIDO D, PASQUALI S, VOLPINI T, SASDELLI M, LOCATELLI F: Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med 310:946-950, 1984
24. WEST ML, JINDAL KK, BEAR R, GOLDSTEIN MB: A controlled trial of cyclophosphamide in patients with membranous glomerulonephritis. Kidney Int 32:579-584, 1987
25. FALK RJ, DALMASSO AP, KIM Y, TSAI CH, SCHEINMAN JI, GEWURZ H, MICHAEL AF: Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease. J Clin Invest 72:560-573, 1983
26. DAVIDSON AM, CAMERON JS, KERR DNS, OGG CS, WILKINSON RW: The natural history of renal function in untreated idiopathic membranous glomerulonephritis in adults. Clin Nephrol 22:61-67, 1984
27. FALK RJ, DALMASSO AP, KIM Y, LAM S, MICHAEL A: Radioimmunoassay of the attack complex of complement in serum from patients with systemic lupus erythematosus. N Engl J Med 312:1594-1599, 1985
28. MORGAN BP, DANIELS RH, WILLIAMS BD: Measurement of terminal complement complexes in rheumatoid arthritis. Clin Exp Immunol 73:473-478, 1988
29. O'DONOGHUE DJ, COUPES B, BRENCHLEY P, SHORT C, BALLARDIE FW: Clinical and autoimmune correlates of complement activation in IgA nephropathy. Int Congr Nephrol 1990, p 391
30. OGRODOWSKI JL, HEBERT LA, SEDMAK D, COSIO FG, TAMERIUS J, KOLB W: Measurement of SC5b-9 in urine in patients with the nephrotic syndrome. Kidney Int 40:1141-1147, 1991
31. KUSUNOKI Y, AKUTSU Y, ITAMI N, TOCHIMARU H, NAGATA Y, TAKEKOSHI Y, SAGAWA A, KATAOKA Y, NAGASAWA S: Urinary excretion of terminal complement complexes in glomerular disease. Nephron 59:27-32, 1991
32. HASUNUMA Y, OHI H, KOJIMA H, FUJITA T, HATANO M: Significance of urinary breakdown products of complement. Int Congr Nephrol 1990, p 362
33. CAMUSSI G, SALVIDIO G, BIESECKER G, BRENTJENS J, ANDRES G: Heymann antibodies induce complement-dependent injury of rat glomerular visceral epithelial cells. J Immunol 139:2906-2914, 1987
34. KERJASCHKI D, SCHULZE M, BINDER S, KAIN R, OJHA PP, MARTIN S, ORVAT R, BAKER PJ, COUSER WG: Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy. J Immunol 143:546-552, 1989